Novo Holdings A/S Q4 2018 Filing

Filed February 14, 2019

Portfolio Value

$710.3B

Holdings

23

Report Date

Q4 2018

Filing Type

13F-HR

All Holdings (23 positions)

#StockSharesValue% PortfolioType
1
INGNINOGEN INC
3,549,320$440.7B62.05%
2
GKOSGLAUKOS CORP
605,266$34.0B4.79%
3
SPNEUSDSEASPINE HLDGS CORP
1,308,037$23.9B3.36%
4
KIDSORTHOPEDIATRICS CORP
654,549$22.8B3.21%
5
SIBNSI BONE INC
892,684$18.6B2.63%
6
XLRNACCELERON PHARMA INC
420,293$18.3B2.58%
7
AM6AMICUS THERAPEUTICS INC
1,867,870$17.9B2.52%
8
AKBAAKEBIA THERAPEUTICS INC
3,100,000$17.1B2.41%
9
AERIEURAERIE PHARMACEUTICALS INC
450,714$16.3B2.29%
10
CRVSCORVUS PHARMACEUTICALS INC
4,420,516$16.2B2.28%
11
DERMIRA INC
1,993,746$14.3B2.02%
12
STIMNEURONETICS INC
525,000$10.2B1.43%
13
ENTASIS THERAPEUTICS HLDGS I
2,181,843$8.9B1.25%
14
GLPGGALAPAGOS NV
87,481$8.0B1.13%
15
INSPINSPIRE MED SYS INC
175,000$7.4B1.04%
16
VRNAVERONA PHARMA PLC
740,740$7.1B1.01%
17
MRUSMERUS N V
502,795$7.0B0.99%
18
NABRIVA THERAPEUTICS PLC
4,703,720$6.9B0.97%
19
MENLO THERAPEUTICS INC
1,269,145$5.2B0.74%
20
CRNXCRINETICS PHARMACEUTICALS IN
135,009$4.0B0.57%
21
TRVCCITIGROUP INC
52,500$2.7B0.38%
22
UNUM THERAPEUTICS INC
569,031$2.5B0.35%
23
WRIGHT MED GROUP N V
4,622,032$60.0M0.01%